The linkages of Raf/MEK/ERK pathway and EMT to miR-429- and/or CRKL-mediated tumor migration and invasion were further validated using PD98059, a specific pERK1/2 inhibitor, for specific signaling blocking. This evidence concerns the gene CRKL and neoplasm.